Surmodics, Inc. (NASDAQ:SRDX) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations And Financial Condition.
Press Release dated January 30, 2019.
SURMODICS INC Exhibit
EX-99.1 2 a51933047ex99_1.htm EXHIBIT 99.1 Exhibit 99.1 Surmodics Reports First Quarter Fiscal 2019 Results Updates Fiscal 2019 Guidance EDEN PRAIRIE,…
To view the full exhibit click
About Surmodics, Inc. (NASDAQ:SRDX)
Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company’s Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company’s In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.